Table 1 Demographic information and clinical features of patients with ENKTL and ocular manifestations.
From: Ocular manifestations of patients with extranodal NK/T-cell lymphoma
Patient number | Sex | Age (yrs) | Site of onset | EBV infection | Chemotherapy | Radiotherapy | Relapse | Follow-up time (mos) | Outcome | |
|---|---|---|---|---|---|---|---|---|---|---|
Asparaginase-based regimens | PD-1 blockade-based regimens | |||||||||
1 | M | 60 | right nasal cavity | + | yes | yes | 0 | no | 11 | alive |
2 | M | 42 | bilateral nasal cavities | + | yes | yes | 28/5040 cGy | yes | 3 | dead |
3 | M | 37 | left nasal cavity | + | yes | yes | 1/not available | yes | 25 | alive |
4 | M | 74 | left maxillary sinus | + | yes | no | 0 | no | 23 | alive |
5 | M | 63 | bilateral nasal cavities | + | yes | yes | 0 | no | 27 | dead |
6 | M | 63 | right nasal cavity | + | yes | yes | 0 | yes | 2 | dead |
7 | M | 49 | left eye | + | yes | yes | 0 | yes | 45 | alive |
8 | M | 45 | right neck | + | yes | yes | 0 | yes | 30 | dead |
9 | M | 55 | left nasal cavity | + | yes | yes | 0 | yes | 33 | dead |
10 | F | 25 | bilateral nasal cavities | + | yes | yes | 25/50 Gy | yes | 33 | alive |
11 | M | 34 | right nasal cavity | + | yes | yes | 28/5040 cGy | yes | 25 | alive |
12 | F | 34 | bilateral nasal cavities | + | yes | yes | 25/50 Gy | yes | 25 | dead |
